{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-014508","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.548221+00:00","generated_at":"2026-06-11T17:38:52.086500+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Helius Medical Q2 revenue up 115% YoY to $256K; net loss narrows to $1.6M","bullets":["Q2 2023 revenue $256K vs $119K in Q2 2022 (+115%); PoNS sales driven by PTAP which ended June 30.","Net loss $1.6M ($0.06 per share) vs $3.8M ($0.97) prior year; operating loss $3.2M.","Cash $8.6M at June 30, 2023; no debt; cash burn $2.7M in Q2 (down $0.9M YoY).","PoNS device awarded DMEPOS accreditation by CMS-authorized TCT, a step toward Medicare reimbursement.","Guidance: Q3 and FY2023 revenue expected above prior year; U.S. sales to shift to cash-pay post-PTAP."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-014508","json":"https://secwatch.observer/filing/0001558370-23-014508.json","markdown":"https://secwatch.observer/filing/0001558370-23-014508.md","text":"https://secwatch.observer/filing/0001558370-23-014508.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023014508/0001558370-23-014508-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023014508/hsdt-20230810x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:38:52.086500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2ee16ee3da846bbf514359d62a4edd76316c75a9","claim":"Solana Co reported the quarter ended June 30, 2023 results: revenue $256 thousand, net income $1.6 million, EPS $0.06 per share. Guidance initiated.","evidence_excerpt":"Total revenue for the second quarter of 2023 was $256 thousand, an increase of $137 thousand compared to $119 thousand in the second quarter of 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023014508/0001558370-23-014508-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$256 thousand"},{"label":"Net income","value":"$1.6 million"},{"label":"EPS","value":"$0.06 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}